세계의 애디슨병 시장 보고서(2025년)

Addison´s Disease Global Market Report 2025

US $ 4,490 ￦ 6,253,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,039,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,824,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

애디슨병 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 9.7%의 성장률(CAGR)로 32억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 첨단 치료제에 대한 수요 증가, 조기 진단에 대한 관심 증가, 선천성 부신 과형성증 유병률 증가, 원격 의료 서비스 확대, 부신 결핵 발병률 증가 등이 주요 요인으로 작용할 것으로 보입니다. 이 시기의 주요 동향으로는 검사 방법의 발전, 호르몬 대체 요법의 혁신, 영상 기술의 개선, 장시간 작용하는 주사제 개발, 진단 도구에 인공지능의 통합 등을 꼽을 수 있습니다.

자가면역질환의 유병률 증가는 애디슨병 시장의 성장을 가속할 것으로 예측됩니다. 자가면역질환은 면역체계가 신체의 건강한 조직을 잘못 공격하여 염증과 손상을 일으켜 발생합니다. 유전적 소인, 오염물질 및 식습관 변화와 같은 환경적 영향, 스트레스 및 운동 부족과 같은 생활습관 등의 요인이 자가면역질환의 발생을 증가시키고 있습니다. 또한 많은 환자들이 여러 가지 자가면역질환을 앓고 있기 때문에 이러한 질환의 유병률 증가는 애디슨병과의 병발 가능성을 높입니다. 예를 들어, 2024년 11월 독일에 기반을 둔 단체인 Versorgungsatlas.de는 2022년 7,324만 1,305명의 보험가입자 중 630만 4,340명이 적어도 한 가지 이상의 자가면역질환 진단을 받았다고 보고했습니다. 결과적으로 자가면역질환의 유병률 증가는 애디슨병 시장 확대에 박차를 가하고 있습니다.

애디슨병 시장의 주요 기업들은 치료 옵션을 늘리고, 환자의 결과를 개선하며, 신체의 자연적인 부신 기능을 자극하여 호르몬 대체 요법에 대한 평생 의존도를 줄일 수 있는 재생 요법과 같은 혁신적인 접근 방식에 초점을 맞추었습니다. 재생 치료는 인간의 세포, 조직 또는 장기를 대체 또는 재생하여 정상 기능을 회복하고 질병, 손상 또는 퇴행성 질환의 치유를 촉진하는 것을 목표로 하는 의료 기술을 포함합니다. 예를 들어, 2024년 7월, 희귀질환 치료를 전문으로 하는 미국 제약회사 Eton Pharmaceuticals, Inc.는 자체 개발한 하이드로코르티손 내복액 ET-400의 신약승인신청(NDA)이 FDA에 의해 승인되었다고 발표하였습니다. 저장 및 운송상의 이점이 개선되어 있습니다. 또한, 정제를 삼키기 어려운 젊은 환자들의 요구를 충족시키기 위해 액상 제형으로 설계되어 보다 정확한 투약이 가능합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 애디슨병 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 애디슨병 시장 : 성장률 분석
• 세계의 애디슨병 시장 실적 : 규모와 성장, 2019-2024
• 세계의 애디슨병 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 애디슨병 전체 시장(TAM)

제6장 시장 세분화

• 세계의 애디슨병 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 원발성 부신 기능 부전
• 2차성 부신 기능 부전
• 3차성 부신 기능 부전
• 세계의 애디슨병 시장 : 약제 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Oral Corticosteroid
• Hydrocortisone
• Fludrocortisone
• Corticosteroid Injections
• 세계의 애디슨병 시장 : 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 임상 검사
• 영상 검사
• 세계의 애디슨병 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 및 진료소
• 진단실험실
• 기타 최종사용자
• 세계의 애디슨병 시장 : 원발성 부신 기능 부전 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 자가면역 애디슨병
• 감염성 애디슨병
• 원발성 부신 기능 부전 기타 원인
• 세계의 애디슨병 시장 : 2차성 부신 기능 부전 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 하수체 기능 부전
• 시상하부 기능 부전
• 세계의 애디슨병 시장 : 3차성 부신 기능 부전 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 장기 스테로이드 사용에 의한 시상하부 또는 하수체 억제
• 3차성 부신 기능 부전의 기타 원인

제7장 지역별/국가별 분석

• 세계의 애디슨병 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 애디슨병 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 애디슨병 시장 : 경쟁 구도
• 애디슨병 시장 : 기업 개요
  • Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
  • Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Novartis AG
• Takeda Pharmaceutical Company Limited
• GlaxoSmithKline plc
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim International GmbH
• Sandoz
• Ipsen S.A.
• Neurocrine Biosciences Inc.
• Recipharm AB
• Accord Healthcare
• Eton Pharmaceuticals
• DuoCort Pharma
• Diurnal Group plc
• Roxane Laboratories Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 애디슨병 시장(2029년) : 새로운 기회를 제공하는 국가
• 애디슨병 시장(2029년) : 새로운 기회를 제공하는 부문
• 애디슨병 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Addison's disease is a rare condition in which the adrenal glands produce insufficient cortisol and aldosterone due to damage, often caused by an autoimmune response. Symptoms include fatigue, muscle weakness, weight loss, low mood, and skin changes. Lifelong hormone replacement therapy is essential to manage the condition and prevent severe complications such as adrenal crisis.

The primary types of Addison's disease include primary, secondary, and tertiary adrenal insufficiency. Primary adrenal insufficiency occurs when the adrenal glands fail to produce adequate cortisol and, in some cases, aldosterone due to damage or dysfunction. Management involves various drug classes, such as oral corticosteroids, hydrocortisone, fludrocortisone, and corticosteroid injections. Diagnosis typically involves laboratory and imaging tests to assess adrenal gland function. Patient care is facilitated by several end-users, including hospitals, clinics, diagnostic laboratories, and other healthcare providers.

The addison's disease market research report is one of a series of new reports from The Business Research Company that provides addison's disease market statistics, including the addison's disease industry global market size, regional shares, competitors with the addison's disease market share, detailed addison's disease market segments, market trends, and opportunities, and any further data you may need to thrive in the addison's disease industry. This addison's disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The addison's disease market size has grown rapidly in recent years. It will grow from $2.05 billion in 2024 to $2.25 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth during the historic period can be attributed to the increasing global incidence of Addison's disease, greater awareness of adrenal insufficiency, rising healthcare expenditure, a higher prevalence of autoimmune diseases, and a growing geriatric population.

The addison's disease market size is expected to see strong growth in the next few years. It will grow to $3.26 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be driven by the rising demand for advanced therapeutics, an increased focus on early diagnosis, a growing prevalence of congenital adrenal hyperplasia cases, the expansion of telemedicine services, and a higher incidence of adrenal tuberculosis. Key trends in this period include advancements in laboratory testing methodologies, innovations in hormone replacement therapies, improvements in imaging technologies, the development of long-acting injectable formulations, and the integration of artificial intelligence in diagnostic tools.

The rising prevalence of autoimmune diseases is expected to drive the growth of the Addison's disease market. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy tissues, leading to inflammation and damage. Factors such as genetic predisposition, environmental influences such as pollutants and dietary changes, and lifestyle aspects such as stress and lack of physical activity contribute to the increasing occurrence of autoimmune diseases. The growing prevalence of these conditions also raises the likelihood of co-occurrence with Addison's disease, as many patients develop multiple autoimmune disorders. For example, in November 2024, Versorgungsatlas.de, a Germany-based organization, reported that in 2022, among 73,241,305 insured individuals, 6,304,340 were diagnosed with at least one autoimmune disease, resulting in a raw prevalence rate of 8.61%, higher than previous estimates of 3% to 9%. As a result, the increasing prevalence of autoimmune diseases is fueling the expansion of the Addison's disease market.

Leading companies in the Addison's disease market are focusing on innovative approaches such as regenerative therapies to enhance treatment options, improve patient outcomes, and potentially reduce lifelong dependence on hormone replacement therapies by stimulating the body's natural adrenal function. Regenerative therapies involve medical techniques aimed at replacing or regenerating human cells, tissues, or organs to restore normal function and promote healing in cases of disease, injury, or degeneration. For instance, in July 2024, Eton Pharmaceuticals, Inc., a US-based pharmaceutical company specializing in treatments for rare diseases, announced that the FDA had accepted its New Drug Application (NDA) for ET-400, a proprietary hydrocortisone oral solution. ET-400 offers improved storage and transport benefits compared to formulations requiring refrigeration. Additionally, its liquid format is designed to meet the needs of young patients who may struggle with swallowing tablets, allowing for more precise dosing.

In November 2022, Neurocrine Biosciences Inc., a US-based biotech company, acquired Diurnal Group plc for $56.5 million. This acquisition strengthens Neurocrine Biosciences' portfolio in rare endocrine disorders by incorporating Diurnal Group's expertise in adrenal hormone therapies. Diurnal Group plc, a UK-based biotech company, specializes in developing treatments for adrenal insufficiency, including Addison's disease.

Major players in the addison's disease market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Bayer AG, Bristol-Myers Squibb Company, Novartis AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz, Ipsen S.A., Neurocrine Biosciences Inc., Recipharm AB, Accord Healthcare, Eton Pharmaceuticals, DuoCort Pharma, Diurnal Group plc, and Roxane Laboratories Inc.

North America was the largest region in the addison's disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in addison's disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the addison's disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The addison's disease market consists of revenues earned by entities by providing services such as diagnostic services, treatment services, and surgical services. The market value includes the value of related goods sold by the service provider or included within the service offering. The addison's disease market also includes sales of adjunct therapies, diagnostic tools, adrenocorticotropic hormone (ACTH) stimulation test kits, blood cortisol, and ACTH testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Addison's Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on addison's disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for addison's disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The addison's disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Primary Adrenal Insufficiency; Secondary Adrenal Insufficiency; Tertiary Adrenal Insufficiency
• 2) By Drug Class: Oral Corticosteroid; Hydrocortisone; Fludrocortisone; Corticosteroid Injections
• 3) By Diagnosis: Laboratory Testing; Imaging Testing
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Primary Adrenal Insufficiency: Autoimmune Addison's Disease; Infectious Addison's Disease; Other causes of primary adrenal insufficiency
• 2) By Secondary Adrenal Insufficiency: Pituitary gland dysfunction; Hypothalamic dysfunction
• 3) By Tertiary Adrenal Insufficiency: Hypothalamic or pituitary suppression due to long-term steroid use; Other causes of tertiary adrenal insufficiency
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Addison's Disease Market Characteristics

3. Addison's Disease Market Trends And Strategies

4. Addison's Disease Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Addison's Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Addison's Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Addison's Disease Market Growth Rate Analysis
• 5.4. Global Addison's Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Addison's Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Addison's Disease Total Addressable Market (TAM)

6. Addison's Disease Market Segmentation

• 6.1. Global Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Primary Adrenal Insufficiency
• Secondary Adrenal Insufficiency
• Tertiary Adrenal Insufficiency
• 6.2. Global Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Corticosteroid
• Hydrocortisone
• Fludrocortisone
• Corticosteroid Injections
• 6.3. Global Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing
• Imaging Testing
• 6.4. Global Addison's Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Other End Users
• 6.5. Global Addison's Disease Market, Sub-Segmentation Of Primary Adrenal Insufficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Autoimmune Addison's Disease
• Infectious Addison's Disease
• Other Causes of Primary Adrenal Insufficiency
• 6.6. Global Addison's Disease Market, Sub-Segmentation Of Secondary Adrenal Insufficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pituitary Gland Dysfunction
• Hypothalamic Dysfunction
• 6.7. Global Addison's Disease Market, Sub-Segmentation Of Tertiary Adrenal Insufficiency, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypothalamic or Pituitary Suppression Due to Long-Term Steroid Use
• Other Causes of Tertiary Adrenal Insufficiency

7. Addison's Disease Market Regional And Country Analysis

• 7.1. Global Addison's Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Addison's Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Addison's Disease Market

• 8.1. Asia-Pacific Addison's Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Addison's Disease Market

• 9.1. China Addison's Disease Market Overview
• 9.2. China Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Addison's Disease Market

• 10.1. India Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Addison's Disease Market

• 11.1. Japan Addison's Disease Market Overview
• 11.2. Japan Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Addison's Disease Market

• 12.1. Australia Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Addison's Disease Market

• 13.1. Indonesia Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Addison's Disease Market

• 14.1. South Korea Addison's Disease Market Overview
• 14.2. South Korea Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Addison's Disease Market

• 15.1. Western Europe Addison's Disease Market Overview
• 15.2. Western Europe Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Addison's Disease Market

• 16.1. UK Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Addison's Disease Market

• 17.1. Germany Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Addison's Disease Market

• 18.1. France Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Addison's Disease Market

• 19.1. Italy Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Addison's Disease Market

• 20.1. Spain Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Addison's Disease Market

• 21.1. Eastern Europe Addison's Disease Market Overview
• 21.2. Eastern Europe Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Addison's Disease Market

• 22.1. Russia Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Addison's Disease Market

• 23.1. North America Addison's Disease Market Overview
• 23.2. North America Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Addison's Disease Market

• 24.1. USA Addison's Disease Market Overview
• 24.2. USA Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Addison's Disease Market

• 25.1. Canada Addison's Disease Market Overview
• 25.2. Canada Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Addison's Disease Market

• 26.1. South America Addison's Disease Market Overview
• 26.2. South America Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Addison's Disease Market

• 27.1. Brazil Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Addison's Disease Market

• 28.1. Middle East Addison's Disease Market Overview
• 28.2. Middle East Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Addison's Disease Market

• 29.1. Africa Addison's Disease Market Overview
• 29.2. Africa Addison's Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Addison's Disease Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Addison's Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Addison's Disease Market Competitive Landscape And Company Profiles

• 30.1. Addison's Disease Market Competitive Landscape
• 30.2. Addison's Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Addison's Disease Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Takeda Pharmaceutical Company Limited
• 31.3. GlaxoSmithKline plc
• 31.4. Amgen Inc.
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Boehringer Ingelheim International GmbH
• 31.7. Sandoz
• 31.8. Ipsen S.A.
• 31.9. Neurocrine Biosciences Inc.
• 31.10. Recipharm AB
• 31.11. Accord Healthcare
• 31.12. Eton Pharmaceuticals
• 31.13. DuoCort Pharma
• 31.14. Diurnal Group plc
• 31.15. Roxane Laboratories Inc.

32. Global Addison's Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Addison's Disease Market

34. Recent Developments In The Addison's Disease Market

35. Addison's Disease Market High Potential Countries, Segments and Strategies

• 35.1 Addison's Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Addison's Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Addison's Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료